Publications by authors named "P Calabro"

Claim this Profile
[
[AQUATIC trial: ending the aspirin era in anticoagulated patients after percutaneous coronary intervention].
Felice Gragnano, Paolo Calabrò

G Ital Cardiol (Rome)· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: The right heart: a key target for cardiovascular medicine.
Maria Concetta Pastore, Simona Sperlongano, Paolo Calabrò, Matteo Cameli

Front Cardiovasc Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention.
Imma Forzano, Domenico Florimonte, Viviana Narciso, Mario Enrico Canonico, Domenico Simone Castiello

J Clin Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute pharmacologic management of myocardial infarction in patients undergoing percutaneous coronary intervention: insights from the Italian nationwide EYESHOT-2 prospective registry.
Marco Zuin, Donata Lucci, Paolo Calabrò, Antonino Nicosia, Emanuele Tizzani

Eur Heart J Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of visit-to-visit LDL-C intraindividual variability in patients treated with PCSK9 inhibitors and inclisiran vs standard lipid-lowering therapy.
Arturo Cesaro, Vincenzo Acerbo, Francesco Scialla, Andrea Zito, Gennaro Porcelli

J Clin Lipidol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis